Claim Missing Document
Check
Articles

Found 2 Documents
Search

Uji Aktivitas Tonikum Ekstrak Etanol Daun Alpukat (Persea Americana Mill.) pada Mencit Jantan (Mus Musculus) Dengan Metode Natatory Exhaustion Padirja, Shyfa Anindya; Hidayat, Imron Wahyu; Agusta, Herma Fanani
Ulul Albab: Majalah Universitas Muhammadiyah Mataram Vol 29, No 2 (2025): Juli
Publisher : Universitas Muhammadiyah Mataram

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.31764/jua.v29i2.34025

Abstract

Abstrak: Penggunaan tonikum semakin populer karena meningkatnya aktivitas masyarakat dalam memenuhi kebutuhan ekonomi. Salah satu tanaman yang berpotensi sebagai tonikum adalah daun alpukat (Persea americana Mill.) karena mengandung senyawa bioaktif seperti flavonoid, alkaloid, polifenol, dan saponin yang dapat memberikan efek tonik. Penelitian ini bertujuan untuk mengetahui kandungan kimia ekstrak etanol daun alpukat dan efek tonikum yang dihasilkan ekstrak etanol daun alpukat. Penelitian termasuk dalam penelitian eksperimental. Identifikasi kandungan kimia menggunakan analisis fitokimia yang ditandai adanya perubahan warna, identifikasi flavonoid dengan kromatografi lapis tipis, dan penetapan kadar flavonoid total dengan spektrofotometri Uv-Vis. Uji tonikum menggunakan metode natatory exhaustion pada 25 ekor mencit yang terbagi menjadi 5 kelompok perlakuan. Kelompok perlakuan terdiri dari Na-CMC 0,5% (kontrol negatif), kafein 100 mg/kgBB (kontrol positif), kelompok seri ekstrak etanol daun alpukat dosis 100, 200, dan 400 mg/kgBB. Data dianalisis menggunakan uji one way ANOVA dan uji lanjut Least Significant Difference (LSD). Hasil penelitian menunjukkan bahwa ekstrak etanol daun alpukat mengandung senyawa flavonoid, alkaloid, tanin, saponin, dan steroid. Ekstrak etanol daun alpukat diketahui mengandung flavonoid dengan rata-rata kadar total sebesar 6,91%. Analisis statistik one way ANOVA (p<0,05) menunjukkan perbedaan signifikan antar kelompok perlakuan dengan nilai 0,001 < 0,05. Uji LSD menunjukkan bahwa kontrol positif tidak berbeda signifikan (p>0,05) dengan kelompok pemberian ekstrak etanol daun alpukat dosis 400 mg/kgBB. Hal ini menunjukkan bahwa pemberian ekstrak dosis 400 mg/kgBB meningkatkan efek tonikum yang sebanding dengan kafein dosis 100 mg/kgBB. Ekstrak etanol daun alpukat mengandung senyawa flavonoid, alkaloid, tanin, saponin, dan steroid dengan rata-rata kandungan flavonoid total sebesar 6,91%. Ekstrak etanol daun alpukat dosis 400 mg/kgBB memberikan efek tonikum terbaik dan sebanding dengan kafein dosis 100 mg/kgBB.Abstract: The use of tonics is becoming increasingly popular due to the rise in societal activities aimed at meeting economic needs. One plant with potential as a tonic is avocado leaves (Persea americana Mill.) because it contains bioactive compounds such as flavonoids, alkaloids, polyphenols, and saponins, which can provide a tonic effect. This study aims to identify the chemical content of avocado leaves ethanol extract and the tonic effect produced by avocado leaves ethanol extract. This study is included in experimental research. Identification of chemical content was conducted using phytochemical analysis indicated by color changes, identification of flavonoids with thinlayer chromatography, and determination of total flavonoid content with UV-Vis spectrophotometry. The tonic test used the natatory exhaustion method on 25 mice divided into 5 treatment groups. The treatment groups consisted of 0.5% Na-CMC (negative control), 100 mg/kgBB caffeine (positive control), and a series of ethanol extract doses from avocado leaves at 100, 200, and 400 mg/kgBB. Data were analyzed using one-way ANOVA and further Least Significant Difference (LSD) tests. The results showed that the ethanol extract of avocado leaves contained flavonoids, alkaloids, tannins, saponins, and steroids. The ethanol extract of avocado leaves is found to contain flavonoids with an average total content of 6.91%. Statistical analysis of one way ANOVA (p<0.05) showed significant differences between treatment groups with a value of 0.001 <0.05. LSD test showed that the positive control was not significantly different (p>0.05) with the group giving the avocado leaf ethanol extract dose of 400 mg/kgBB. This indicates that the administration of the extract at a dose of 400 mg/kgBB enhances the tonic effect to a level comparable with 100 mg/kgBB of caffeine.The ethanol extract of avocado leaves contains flavonoid, alkaloid, tannin, saponin, and steroid compounds with an average total flavonoid content of 6.91%. The ethanol extract of avocado leaves dose 400 mg/kgBB offers the best tonic effect and comparable to caffeine dose 100 mg/kgBB.
Exploring the Role of Progression Free Survival in Chemotherapy Protocol: A Literatur Review: Telaah Pustaka Penilaian Progression Free Survival Sebagai Parameter Klinis Tata Terapi Kanker Padirja, Shyfa Anindya; Rahayu, Ngesti; Fitria, Tisa; Fasya, Saniya Puspa; Umma, Nafa; Zahrah, Salsabila Salma; Santoso, Setiyo Budi
Prosiding University Research Colloquium Proceeding of The 18th University Research Colloquium 2023: Bidang MIPA dan Kesehatan
Publisher : Konsorsium Lembaga Penelitian dan Pengabdian kepada Masyarakat Perguruan Tinggi Muhammadiyah 'Aisyiyah (PTMA) Koordinator Wilayah Jawa Tengah - DIY

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Progression-Free Survival (PFS) measures cancer patients' resistance to tumor progression. This alternative measurement is effective in assessing the performance of cancer therapy protocols and may serve an evidence for evaluating the quality of life of patients and planning follow-up treatments. Here in, we review a number of PFS data publications for drugs used in cancer therapy. The review involves ten scientific articles met the inclusion criteria provided by the PubMed database. Our finding present the optimal performance of chemotherapy protocols in preventing disease progression in seven various cancer populations. The highest PFS values for each cancer such as: crizotinib for lung cancer (28.71 months), enzalutamide for prostate cancer (7.1 months), pamiparib for stomach cancer (3.7 months), anlotinib for liver cancer (4.2 months), irinotecan plus raltitrexed for esophageal cancer (3.91 months), folfoxiri plus bevacizumab for metastatic colorectal cancer (10.7 months), and paclitaxel plus vistusertib for ovarian carcinoma (4.5 months).